Last updated on July 2020

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Obesity | Overweight
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Body mass Index (BMI) 30 kilograms per square meter (kg/m), or 27 kg/m and previous diagnosis with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease
  • History of at least one unsuccessful dietary effort to lose body weight

Exclusion Criteria:

  • Diabetes mellitus
  • Change in body weight greater than 5 kg within 3 months prior to starting study
  • Obesity induced by other endocrinologic disorders or monogenetic or syndromic forms of obesity
  • History of pancreatitis
  • Family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2)
  • History of significant active or unstable major depressive disorder (MDD) or other severe psychiatric disorder within the last 2 years
  • Any lifetime history of a suicide attempt

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.